Abstract

Unilever PLC will release its quarterly results on February 12, 2026 Pre-Market; this preview summarizes recent performance, last quarter’s key metrics, and the market’s baseline expectations while highlighting the main business dynamics and prevailing analyst views.

Market Forecast

Based on currently available consolidated expectations, the market anticipates a steady quarter for Unilever PLC, with modest revenue growth and stable profitability metrics; however, no formal consensus figures for adjusted EPS, revenue, or margin were disclosed in official forecasts within the specified period. From the company’s prior disclosures, investors are focused on revenue stability across core categories, with gross profit margin and net profit margin expected to remain range-bound year over year, and adjusted EPS seen broadly stable; year-over-year comparisons are expected to reflect limited pricing tailwinds.

The main business is expected to maintain a balanced mix across Food, Personal Care, Beauty & Wellbeing, Home Care, and Ice Cream, with continued mix improvement supporting margin resilience and cost discipline sustaining cash generation. Beauty & Wellbeing is viewed by many market participants as the most promising segment, driven by premiumization and innovation; it accounted for an estimated 6.49 billion last quarter with steady year-over-year momentum.

Last Quarter Review

In the last reported quarter, Unilever PLC delivered revenue across its primary segments totaling 29.13 billion, a gross profit margin of 100.00%, net profit attributable to the parent company of 1.76 billion, a net profit margin of 11.66%, and adjusted EPS not disclosed; the sequential net profit growth rate was 0.00% per the available dataset.

Unilever PLC’s segment mix showed scale across Food at 6.57 billion and Personal Care at 6.55 billion, with Beauty & Wellbeing at 6.49 billion supporting premium categories. The main business highlight centered on stable category demand and portfolio discipline, while segment revenues suggested broadly balanced contributions across the five pillars.

Current Quarter Outlook

Main business: Core categories look steady with pricing normalization and disciplined promotion

Unilever PLC’s core businesses—Food, Personal Care, Beauty & Wellbeing, Home Care, and Ice Cream—are positioned for a generally steady quarter as pricing normalization works through the base and volumes gradually recover. Category inflation has moderated compared with the prior year, and the company’s prior actions to rebuild competitiveness through sharper price-pack architecture and targeted promotion should support underlying volume. Input-cost volatility remains a consideration, but the company has historically executed well on productivity and savings programs, which can buffer inflationary pressure and support gross margin stability. The portfolio’s diversification by category and geography also diversifies risk, helping mitigate softness in any single market.

Most promising business: Beauty & Wellbeing primed for premium-led growth and mix accretion

Beauty & Wellbeing remains the segment with the strongest structural growth drivers, benefitting from premiumization, innovation cadence, and expanding distribution across digital and specialty retail channels. The category’s mix tilt toward higher-margin SKUs positions it to lift group gross margin even if overall revenue growth is modest. International brand equity and product renovation cycles tend to underpin pricing power, while a larger share of direct-to-consumer and e-commerce exposure supports data-driven marketing and demand sensing. Execution risks include competition from local and indie brands and potential normalization in certain hero franchises, but sustained R&D and brand support should maintain momentum.

Key stock drivers this quarter: Volumes vs pricing, input costs, and execution on savings

The share price reaction this quarter will likely hinge on the balance between volume recovery and pricing normalization. Investors will parse commentary on elasticities and whether promotional intensity is required to defend share, which could influence near-term margins. Commodity and logistics inputs are another central variable; benign trends would support gross margin resilience and cash generation, while any resurgence in feedstock or freight costs could pressure profitability. Finally, progress on cost savings, working capital discipline, and capital allocation will frame the outlook for free cash flow, which remains a core support for returns.

Analyst Opinions

Recent sell-side and institutional views generally lean neutral-to-cautious, reflecting an expectation for steady but unspectacular revenue growth and margin stability. Commentary emphasizes that valuation already discounts gradual improvement, so the bar for positive revision rests on clear evidence of volume-led growth and durable premium mix gains in Beauty & Wellbeing. Analysts also highlight potential upside from continued portfolio pruning and reinvestment in higher-return categories, balanced by risks including promotional intensity in developed markets and uneven consumer demand in select emerging markets.

On balance, the majority stance is a wait-and-see approach with modestly positive bias toward segments with premium positioning. Institutions point to Beauty & Wellbeing as the likely outperformer if marketing investment converts into sustained share gains and if e-commerce channels deliver incremental reach and pricing power. The near-term narrative centers on confirmation that pricing is holding without eroding volume and that cost savings are sufficient to protect margins amid input-cost uncertainties. If these conditions are met, analysts suggest incremental upside to earnings trajectory, though the prevailing view stops short of a broadly bullish call absent clearer acceleration in volumes and cash flow growth.